1. Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease

   • Melissa H. Roberts
   • Douglas W. Mapel
   • Hans Petersen

   Original Research Article Open access 02 December 2019 Pages: 1 - 17

   

2. Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate

   • Charmi Patel
   • Bruno Emond
   • Antoine C. El Khoury

   Original Research Article Open access 30 November 2019 Pages: 19 - 29

   

3. Effectiveness of V-Go^® for Patients with Type 2 Diabetes in a Real-World Setting: A Prospective Observational Study

   • George Grunberger
   • Cheryl R. Rosenfeld
   • Poul Strange

   Original Research Article Open access 12 December 2019 Pages: 31 - 40

   

4. Severe Cutaneous Adverse Drug Reactions Associated with Allopurinol: An Analysis of Spontaneous Reporting System in Southern Italy

   • Cristina Scavone
   • Cristina Di Mauro
   • Annalisa Capuano

   Original Research Article Open access 17 December 2019 Pages: 41 - 51

   

5. Medication Discrepancies in Discharge Summaries and Associated Risk Factors for Elderly Patients with Many Drugs

   • Gabriella Caleres
   • Sara Modig
   • Åsa Bondesson

   Original Research Article Open access 13 December 2019 Pages: 53 - 62

   

6. Clinical Relevance of CYP2D6 Polymorphisms in Patients of an Austrian Medical Practice: A Family Practice-Based Observational Study

   • Gustav Kamenski
   • Seda Ayazseven
   • Helene Pühringer

   Original Research Article Open access 20 December 2019 Pages: 63 - 73

   

7. Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational Study

   • Nestor Szerman
   • Ignacio Basurte-Villamor
   • Francisco Arias

   Original Research Article Open access 05 February 2020 Pages: 75 - 83

   

8. Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational Study

   • Nestor Szerman
   • Ignacio Basurte-Villamor
   • Francisco Arias

   Correction Open access 28 February 2020 Pages: 85 - 85

9. Drug Prescription in Older Swiss Men and Women Followed in Family Medicine

   • David Schnegg
   • Nicolas Senn
   • Yolanda Mueller

   Short Communication Open access 17 December 2019 Pages: 87 - 95